{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:44:51Z","timestamp":1787179491848,"version":"build-2736575974"},"reference-count":250,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease, with advanced stages potentially progressing to hepatocellular carcinoma. It is a multifactorial condition associated with metabolic syndrome, diabetes, and hormonal imbalance, leading to metabolic alterations that are intensified by inflammation. An important additional factor that amplifies these effects is oxidative stress, which interacts with inflammatory pathways and contributes to disease progression. This review evaluates evidence from in vitro, in vivo, and clinical studies on widely investigated natural compounds, including cinnamic acid, stilbene and quinone derivatives, coumarinoids, tannins, and miscellaneous phenol-containing compounds and alkaloids, focusing on their antioxidant, anti-inflammatory and multi-functional properties. These compounds have demonstrated beneficial effects such as reduction of lipid accumulation, improvement of insulin resistance, modulation of inflammatory cytokines (e.g., TNF-\u03b1, IL-6), and attenuation of oxidative stress markers, with several studies reporting improvements in liver enzymes and histological features of steatosis. The aim is to assess their potential to improve NAFLD beyond their established biological activities and to explore their repositioning potential as multi-targeted agents for complementary or second-line therapeutic strategies. Their plant-derived origin and broad therapeutic profiles suggest a favorable safety margin. However, further well-designed clinical studies are required to better define their efficacy, optimal dosing, pharmacokinetics and safety, as well as to clarify their mechanisms of action and their potential role in NAFLD management.<\/jats:p>","DOI":"10.3390\/cimb48050465","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:01:18Z","timestamp":1777474878000},"page":"465","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Natural Plant-Derived Compounds Targeting Oxidative Stress and Inflammation in NAFLD\u2014Mechanisms and Repositioning Potential"],"prefix":"10.3390","volume":"48","author":[{"given":"Rafailia-Eirini","family":"Theodorou","sequence":"first","affiliation":[{"name":"Department of Pharmacy, School of Health Sciences, Frederick University, Nicosia 1036, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikiforos","family":"Vrettos","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health Sciences, Frederick University, Nicosia 1036, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Theodosis-Nobelos","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health Sciences, Frederick University, Nicosia 1036, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a Continuum: From Obesity to Metabolic Syndrome and Diabetes","volume":"12","author":"Valerio","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/HYPERTENSIONAHA.119.13419","article-title":"Nonalcoholic Fatty Liver Disease","volume":"75","author":"Zhao","year":"2020","journal-title":"Hypertension"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and Resolution of Inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.reprotox.2016.10.001","article-title":"Metabolism Disrupting Chemicals and Metabolic Disorders","volume":"68","author":"Heindel","year":"2017","journal-title":"Reprod. Toxicol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"14185","DOI":"10.3748\/wjg.v20.i39.14185","article-title":"Nonalcoholic Fatty Liver Disease and Aging: Epidemiology to Management","volume":"20","author":"Bertolotti","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.metabol.2017.04.011","article-title":"Non-Alcoholic Fatty Liver Disease: A Sign of Systemic Disease","volume":"72","author":"Reccia","year":"2017","journal-title":"Metabolism"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.freeradbiomed.2013.08.174","article-title":"Free Radical Biology for Medicine: Learning from Nonalcoholic Fatty Liver Disease","volume":"65","author":"Serviddio","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"154203","DOI":"10.1016\/j.metabol.2020.154203","article-title":"Current and Emerging Pharmacological Options for the Treatment of Nonalcoholic Steatohepatitis","volume":"111","author":"Polyzos","year":"2020","journal-title":"Metabolism"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD Development and Therapeutic Strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"154925","DOI":"10.1016\/j.metabol.2021.154925","article-title":"Insights into the Molecular Targets and Emerging Pharmacotherapeutic Interventions for Nonalcoholic Fatty Liver Disease","volume":"126","author":"Negi","year":"2022","journal-title":"Metabolism"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s12072-024-10702-5","article-title":"MAFLD ICD-11 Coding Collaborators. A Global Survey on the Use of the International Classification of Diseases Codes for Metabolic Dysfunction-Associated Fatty Liver Disease","volume":"18","author":"Zhang","year":"2024","journal-title":"Hepatol. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.1097\/HEP.0000000000000695","article-title":"Letter to the Editor: A Multi-Society Delphi Consensus Statement on New Fatty Liver Disease Nomenclature","volume":"79","author":"Hoofnagle","year":"2024","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101506","DOI":"10.1016\/j.diabet.2023.101506","article-title":"Steatotic Liver Disease, MASLD and Risk of Chronic Kidney Disease","volume":"50","author":"Bilson","year":"2024","journal-title":"Diabetes Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","article-title":"Lipidomic Biomarkers and Mechanisms of Lipotoxicity in Non-Alcoholic Fatty Liver Disease","volume":"144","author":"Pierantonelli","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"155241","DOI":"10.1016\/j.metabol.2022.155241","article-title":"Higd1a Facilitates Exercise-Mediated Alleviation of Fatty Liver in Diet-Induced Obese Mice","volume":"134","author":"Zhu","year":"2022","journal-title":"Metabolism"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Packard, C.J., Boren, J., and Taskinen, M.R. (2020). Causes and Consequences of Hypertriglyceridemia. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00252"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Jangra, A., Kothari, A., Sarma, P., Medhi, B., Omar, B.J., and Kaushal, K. (2022). Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis. Cells, 11.","DOI":"10.3390\/cells11091500"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13578-021-00731-0","article-title":"Antioxidant Supplements Promote Tumor Formation and Growth and Confer Drug Resistance in Hepatocellular Carcinoma by Reducing Intracellular ROS and Induction of TMBIM1","volume":"11","author":"Zhang","year":"2021","journal-title":"Cell Biosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep4.1801","article-title":"Role of Cholesterol-Associated Steatohepatitis in the Development of NASH","volume":"6","author":"Horn","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Cou\u00e9, M., Falewee, J., Aguesse, A., and Croyal, M. (2019). Spirulina Liquid Extract Protects against Fibrosis Related to Non-Alcoholic Steatohepatitis and Increases Ursodeoxycholic Acid. Nutrients, 11.","DOI":"10.3390\/nu11010194"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","article-title":"Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease","volume":"1061","author":"Farrell","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1194\/jlr.M072454","article-title":"Cholesterol Crystallization within Hepatocyte Lipid Droplets and Its Role in Murine NASH","volume":"58","author":"Ioannou","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathmechdis-012418-013003","article-title":"Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases","volume":"14","author":"Cai","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/hep.30705","article-title":"Integrated Omics Reveals Tollip as a Regulator and Therapeutic Target for Hepatic Ischemia\u2013Reperfusion Injury in Mice","volume":"70","author":"Yan","year":"2019","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2119\/molmed.2016.00054","article-title":"Superoxide Induces Neutrophil Extracellular Trap Formation in a TLR-4- and NOX-Dependent Mechanism","volume":"22","author":"Tohme","year":"2016","journal-title":"Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s11064-022-03821-8","article-title":"Efforts towards Repurposing of Antioxidant Drugs and Active Compounds for Multiple Sclerosis Control","volume":"48","author":"Rekka","year":"2023","journal-title":"Neurochem. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.tem.2018.08.003","article-title":"Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease","volume":"29","author":"Cai","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.redox.2018.09.025","article-title":"New Insights into Oxidative Stress and Inflammation during Diabetes Mellitus\u2013Accelerated Atherosclerosis","volume":"20","author":"Yuan","year":"2019","journal-title":"Redox Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1801585","DOI":"10.1002\/advs.201801585","article-title":"Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases","volume":"6","author":"Yu","year":"2019","journal-title":"Adv. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.freeradbiomed.2013.10.009","article-title":"Contribution of Endogenously Produced Reactive Oxygen Species to the Activation of Podocyte NLRP3 Inflammasomes in Hyperhomocysteinemia","volume":"67","author":"Abais","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101122","DOI":"10.1016\/j.redox.2019.101122","article-title":"Implication of Oxidative Stress in the Pathogenesis of Systemic Sclerosis via Inflammation, Autoimmunity and Fibrosis","volume":"25","author":"Doridot","year":"2019","journal-title":"Redox Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of Fatty Acids Stored in Liver and Secreted via Lipoproteins in Patients with Nonalcoholic Fatty Liver Disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.tem.2019.08.006","article-title":"Emerging Molecular Targets for Treatment of Non-Alcoholic Fatty Liver Disease","volume":"30","author":"Chen","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","article-title":"Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies","volume":"28","author":"Sunny","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1194\/jlr.M023382","article-title":"Elevated TCA Cycle Function in the Pathology of Diet-Induced Hepatic Insulin Resistance and Fatty Liver","volume":"53","author":"Satapati","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial Adaptations and Dysfunctions in Nonalcoholic Fatty Liver Disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Mooli, R.G.R., and Ramakrishnan, S.K. (2022). Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.946474"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Theodosis-Nobelos, P., and Rekka, E.A. (2024). The Antioxidant Potential of Vitamins and Their Implication in Metabolic Abnormalities. Nutrients, 16.","DOI":"10.3390\/nu16162740"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of Nonalcoholic Fatty Liver Disease\/Nonalcoholic Steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Carnagarin, R., Tan, K., Adams, L., Matthews, V.B., and Kiuchi, M.G. (2021). Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)\u2014A Condition Associated with Heightened Sympathetic Activation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084241"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Yadati, T., Bitorina, A., Oligschlaeger, Y., Gijbels, M.J., and Mohren, R. (2021). Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammation in NASH Mice. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.675535"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Urso, C.J., and Zhou, H. (2021). Palmitic Acid Lipotoxicity in Microglia Cells Is Ameliorated by Unsaturated Fatty Acids. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22169093"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"108751","DOI":"10.1016\/j.jnutbio.2021.108751","article-title":"Consumption of Soybean or Olive Oil at Recommended Concentrations Increased the Intestinal Microbiota Diversity and Insulin Sensitivity and Prevented Fatty Liver Compared to the Effects of Coconut Oil","volume":"94","author":"Tapia","year":"2021","journal-title":"J. Nutr. Biochem."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Geethangili, M., Lin, C.W., Mersmann, H.J., and Ding, S.T. (2021). Methyl Brevifolincarboxylate Attenuates Free Fatty Acid-Induced Lipid Metabolism and Inflammation in Hepatocytes through AMPK\/NF-\u03baB Signaling Pathway. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221810062"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"44612","DOI":"10.1038\/srep44612","article-title":"Effect of Modulation of PPAR-\u03b3 Activity on Kupffer Cells M1\/M2 Polarization in the Development of Non-Alcoholic Fatty Liver Disease","volume":"7","author":"Luo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s10753-017-0628-z","article-title":"NLRP3 Deletion Inhibits the Non-Alcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic Acid","volume":"40","author":"Cai","year":"2017","journal-title":"Inflammation"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Welch, R.D., Billon, C., Losby, M., Bedia-Diaz, G., Fang, Y., Avdagic, A., Elgendy, B., Burris, T.P., and Griffett, K. (2022). Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH. Metabolites, 12.","DOI":"10.3390\/metabo12030238"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic Reticulum Stress Signalling and the Pathogenesis of Non-Alcoholic Fatty Liver Disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.molcel.2009.02.017","article-title":"BAX Inhibitor-1 Is a Negative Regulator of the ER Stress Sensor IRE1\u03b1","volume":"33","author":"Lisbona","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hep.20999","article-title":"JNK1 but Not JNK2 Promotes the Development of Steatohepatitis in Mice","volume":"43","author":"Schattenberg","year":"2006","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"a033910","DOI":"10.1101\/cshperspect.a033910","article-title":"Redox-Mediated Regulatory Mechanisms of Endoplasmic Reticulum Homeostasis","volume":"11","author":"Ushioda","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zeeshan, H.M.A., Lee, G.H., Kim, H.R., and Chae, H.J. (2016). Endoplasmic Reticulum Stress and Associated ROS. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030327"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.freeradbiomed.2015.05.027","article-title":"Endoplasmic Reticulum Stress and Nrf2 Signaling in Cardiovascular Diseases","volume":"88","author":"Cominacini","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"G283","DOI":"10.1152\/ajpgi.00296.2009","article-title":"Deletion of Nuclear Factor-E2-Related Factor-2 Leads to Rapid Onset and Progression of Nutritional Steatohepatitis in Mice","volume":"298","author":"Sugimoto","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.trsl.2017.11.007","article-title":"Nrf2-p62 Autophagy Pathway and Its Response to Oxidative Stress in Hepatocellular Carcinoma","volume":"193","author":"Bartolini","year":"2018","journal-title":"Transl. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","article-title":"AMPK as a Therapeutic Target for Treating Metabolic Diseases","volume":"28","author":"Day","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"33154","DOI":"10.1074\/jbc.M110.143685","article-title":"Exposure to Hydrogen Peroxide Induces Oxidation and Activation of AMP-Activated Protein Kinase","volume":"285","author":"Zmijewski","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1423-0127-19-32","article-title":"Effects of L-Carnitine against Oxidative Stress in Human Hepatocytes: Involvement of Peroxisome Proliferator-Activated Receptor Alpha","volume":"19","author":"Li","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.freeradbiomed.2010.03.007","article-title":"Oxidative Stress Modulates PPAR\u03b3 in Vascular Endothelial Cells","volume":"48","author":"Blanquicett","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2008.08.068","article-title":"Oxidative Stress Induced Lipid Accumulation via SREBP1c Activation in HepG2 Cells","volume":"375","author":"Sekiya","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/MCB.22.4.1016-1026.2002","article-title":"Molecular Mechanism of Insulin-Induced Degradation of Insulin Receptor Substrate 1","volume":"22","author":"Zhande","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Iwakami, S., Misu, H., Takeda, T., Sugimori, M., Matsugo, S., Kaneko, S., and Takamura, T. (2011). Concentration-Dependent Dual Effects of Hydrogen Peroxide on Insulin Signal Transduction in H4IIEC Hepatocytes. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027401"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1152\/ajpendo.00441.2010","article-title":"Coffee Polyphenols Suppress Diet-Induced Body Fat Accumulation by Downregulating SREBP-1c and Related Molecules in C57BL\/6J Mice","volume":"300","author":"Murase","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How Does Hepatic Lipid Accumulation Lead to Lipotoxicity in Nonalcoholic Fatty Liver Disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol. Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.3748\/wjg.v29.i25.3999","article-title":"Insulin Resistance and Adipose Tissue Interactions as the Cornerstone of Metabolic (Dysfunction)-Associated Fatty Liver Disease Pathogenesis","volume":"29","author":"Pal","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Nonalcoholic Fatty Liver Disease: The Interplay Between Metabolism, Microbes and Immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e70080","DOI":"10.1096\/fba.2025-00218","article-title":"The Gut Microbiota\u2013Insulin Resistance Axis: Mechanisms, Clinical Implications, and Therapeutic Potential","volume":"8","author":"Chaarani","year":"2026","journal-title":"FASEB BioAdv."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"101226","DOI":"10.1016\/j.focha.2026.101226","article-title":"Dietary Phytochemicals as Multitarget Strategies against Metabolic Syndrome: Mechanistic Basis and Translational Outlook","volume":"10","author":"Simanjuntak","year":"2026","journal-title":"Food Chem. Adv."},{"key":"ref_74","unstructured":"Moeini, A., Sabouri, S., Shariat-Panahi, S.S., Khodadadi, S., and Malekigorji, M. (2024). Dietary Polyphenols and Gut Microbiota Cross-Talk: Symbiotic Interactions and Their Implications for Cardiometabolic Health. Nutrients, 16."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Li, H., Gao, J., Peng, W., Sun, X., Qi, W., and Wang, Y. (2025). Dietary Polyphenols\u2013Gut Microbiota Interactions: Intervention Strategies and Metabolic Regulation for Intestinal Diseases. Biology, 14.","DOI":"10.3390\/biology14121705"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.metabol.2012.04.006","article-title":"Caffeic Acid Phenethyl Ester Reduces the Activation of the Nuclear Factor \u03baB Pathway by High-Fat Diet-Induced Obesity in Mice","volume":"61","author":"Bezerra","year":"2012","journal-title":"Metabolism"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Theodosis-Nobelos, P., Marc, G., and Rekka, E.A. (2024). Design, Synthesis, and Evaluation of Antioxidant and NSAID Derivatives with Antioxidant, Anti-Inflammatory, and Plasma Lipid Lowering Effects. Molecules, 29.","DOI":"10.3390\/molecules29051016"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.nut.2018.03.010","article-title":"Caffeic Acid Ameliorates Hepatic Steatosis and Reduces ER Stress in High-Fat Diet-Induced Obese Mice by Regulating Autophagy","volume":"55\u201356","author":"Kim","year":"2018","journal-title":"Nutrition"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Stanciauskaite, M., Poskute, M., Kurapkiene, V., Marksa, M., Jakstas, V., Ivanauskas, L., Kersiene, M., Leskauskaite, D., and Ramanauskiene, K. (2023). Optimization of Delivery and Bioavailability of Encapsulated Caffeic Acid. Foods, 12.","DOI":"10.3390\/foods12101993"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1248\/bpb.b14-00137","article-title":"Evaluation of Hepatocyte-Protective and Anti-Hepatitis B Virus Properties of Cichoric Acid from Cichorium intybus Leaves in Cell Culture","volume":"37","author":"Zhang","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.foodres.2013.07.033","article-title":"Chicoric Acid Prevents Obesity by Attenuating Hepatic Steatosis, Inflammation, and Oxidative Stress in High-Fat Diet-Fed Mice","volume":"54","author":"Xiao","year":"2013","journal-title":"Food Res. Int."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/jmf.2013.2799","article-title":"Crepidiastrum denticulatum Extract Protects the Liver against Chronic Alcohol-Induced Damage and Fat Accumulation in Rats","volume":"17","author":"Yoo","year":"2014","journal-title":"J. Med. Food"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1600500","DOI":"10.1002\/mnfr.201600632","article-title":"Chicoric Acid Attenuates Nonalcoholic Steatohepatitis by Inhibiting Key Regulators of Lipid Metabolism, Fibrosis, Oxidation, and Inflammation in Mice with Methionine and Choline Deficiency","volume":"61","author":"Kim","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_84","first-page":"97","article-title":"Determination of Chicoric Acid Content in Plasma and Urine of Rats by Ultra-Performance Liquid Chromatography and Related Pharmacokinetic Study","volume":"57","author":"Wang","year":"2021","journal-title":"Chin. J. Vet. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.2174\/1381612811319150009","article-title":"Redox Homeostasis and Epigenetics in Non-Alcoholic Fatty Liver Disease (NAFLD)","volume":"19","author":"Podrini","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"100055","DOI":"10.1016\/j.phyplu.2021.100055","article-title":"Evidence for the Anti-NAFLD Effectiveness of Chlorogenic Acid as a HAT Inhibitor Using In Vivo Experiments Supported by Virtual Molecular Docking","volume":"1","author":"Xu","year":"2021","journal-title":"Phytomed. Plus"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jn\/131.1.66","article-title":"Chlorogenic Acid and Caffeic Acid Are Absorbed in Humans","volume":"131","author":"Olthof","year":"2001","journal-title":"J. Nutr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1124\/dmd.111.040147","article-title":"Absorption and Metabolism of Chlorogenic Acids in Cultured Gastric Epithelial Monolayers","volume":"39","author":"Farrell","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","article-title":"miR-122\u2014A Key Factor and Therapeutic Target in Liver Disease","volume":"62","author":"Bandiera","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/liv.12633","article-title":"microRNA-122 Regulates Hypoxia-Inducible Factor-1 and Vimentin in Hepatocytes and Correlates with Fibrosis in Diet-Induced Steatohepatitis","volume":"35","author":"Csak","year":"2015","journal-title":"Liver Int."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.fct.2007.01.011","article-title":"Hepatoprotective and Antioxidative Effects of Total Phenolics from Laggera pterodonta on Chemical-Induced Injury in Primary Cultured Neonatal Rat Hepatocytes","volume":"45","author":"Wu","year":"2007","journal-title":"Food Chem. Toxicol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jep.2012.09.003","article-title":"Hepatoprotective and Antiviral Properties of Isochlorogenic Acid A from Laggera alata against Hepatitis B Virus Infection","volume":"144","author":"Hao","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/bcpt.13122","article-title":"Protective Effect of Isochlorogenic Acid B on Liver Fibrosis in Non-Alcoholic Steatohepatitis of Mice","volume":"124","author":"Liu","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.2147\/DDDT.S315724","article-title":"Nonalcoholic Steatohepatitis (NASH): A Review of a Crowded Clinical Landscape, Driven by a Complex Disease","volume":"15","author":"Fraile","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.ejmech.2010.01.066","article-title":"Synthesis, Structure, and Structure-Activity Relationship Analysis of Caffeic Acid Amides as Potential Antimicrobials","volume":"45","author":"Fu","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.phymed.2014.11.013","article-title":"Two Cinnamoyloctopamine Antioxidants from Garlic Skin Attenuate Oxidative Stress and Liver Pathology in Rats with Non-Alcoholic Steatohepatitis","volume":"22","author":"Wu","year":"2015","journal-title":"Phytomedicine"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Wu, J., Xue, X., Fan, G., Gu, Y., Zhou, F., Zheng, Q., Liu, R., Li, Y., Ma, B., and Li, S. (2021). Ferulic Acid Ameliorates Hepatic Inflammation and Fibrotic Liver Injury by Inhibiting PTP1B Activity and Subsequent Promoting AMPK Phosphorylation. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.754976"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Moore, J., Yousef, M., and Tsiani, E. (2016). Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols. Nutrients, 8.","DOI":"10.3390\/nu8110731"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Liang, Z., Xu, Y., Wen, X., Nie, H., Hu, T., Yang, X., Chu, X., Yang, J., Deng, X., and He, J. (2016). Rosmarinic Acid Attenuates Airway Inflammation and Hyperresponsiveness in a Murine Model of Asthma. Molecules, 21.","DOI":"10.3390\/molecules21060769"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yebeh.2016.06.037","article-title":"Rosmarinic Acid Is Anticonvulsant against Seizures Induced by Pentylenetetrazol and Pilocarpine in Mice","volume":"62","author":"Grigoletto","year":"2016","journal-title":"Epilepsy Behav."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.fct.2012.10.021","article-title":"Rosmarinic Acid Ameliorates Acute Liver Damage and Fibrogenesis in Carbon Tetrachloride-Intoxicated Mice","volume":"51","author":"Domitrovic","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/rej.2018.2107","article-title":"Rosmarinic Acid Ameliorates H2O2-Induced Oxidative Stress in L02 Cells through MAPK and Nrf2 Pathways","volume":"22","author":"Ding","year":"2019","journal-title":"Rejuvenation Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1039\/C6RA28237G","article-title":"Pharmacokinetics of Rosmarinic Acid in Rats by LC-MS\/MS: Absolute Bioavailability and Dose Proportionality","volume":"7","author":"Wang","year":"2017","journal-title":"RSC Adv."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1021\/acs.jafc.7b06008","article-title":"Anti-inflammatory and Antioxidant Activities from the Basolateral Fraction of Caco-2 Cells Exposed to a Rosmarinic Acid Enriched Extract","volume":"66","author":"Villalva","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Bla\u017eevi\u0107, T., Reznicek, G., Ding, L., Yang, G., Haiss, P., Heiss, E.H., Dirsch, V.M., and Liu, R. (2021). Short Chain (\u2264C4) Esterification Increases Bioavailability of Rosmarinic Acid and Its Potency to Inhibit Vascular Smooth Muscle Cell Proliferation. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.609756"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/mnfr.201500490","article-title":"Punicalagin Attenuates Palmitate-Induced Lipotoxicity in HepG2 Cells by Activating the Keap1-Nrf2 Antioxidant Defense System","volume":"60","author":"Yan","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jff.2019.03.006","article-title":"Protective Mechanism of Punicalagin against Endoplasmic Reticulum Stress in the Liver of Mice with Type 2 Diabetes Mellitus","volume":"56","author":"Mo","year":"2019","journal-title":"J. Funct. Foods"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1089\/ars.2013.5538","article-title":"Mitochondrial Dysfunction in Obesity-Associated Nonalcoholic Fatty Liver Disease: The Protective Effects of Pomegranate with Its Active Component Punicalagin","volume":"21","author":"Zou","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e2001031","DOI":"10.1002\/mnfr.202001031","article-title":"Punicalagin Prevents Hepatic Steatosis through Improving Lipid Homeostasis and Inflammation in Liver and Adipose Tissue and Modulating Gut Microbiota in Western Diet-Fed Mice","volume":"65","author":"Liu","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.intimp.2013.06.032","article-title":"Schizandrin C Exerts Anti-Neuroinflammatory Effects by Upregulating Phase II Detoxifying\/Antioxidant Enzymes in Microglia","volume":"17","author":"Park","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"152760","DOI":"10.1016\/j.phymed.2018.11.020","article-title":"Schisandra Fruits for the Management of Drug-Induced Liver Injury in China: A Review","volume":"59","author":"Zhu","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nutres.2019.01.001","article-title":"Schizandrin A Supplementation Improves Nonalcoholic Fatty Liver Disease in Mice Fed a High-Fat and High-Cholesterol Diet","volume":"64","author":"Jeong","year":"2019","journal-title":"Nutr. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"105245","DOI":"10.1016\/j.fbio.2024.105245","article-title":"Schisandrin A Alleviates Non-Alcoholic Fatty Liver Disease by Improving Liver Metabolic Disorders and Suppressing the GSK3\u03b2 Signaling Pathway","volume":"62","author":"Li","year":"2024","journal-title":"Food Biosci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6171658","DOI":"10.1155\/2016\/6171658","article-title":"Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver Disease","volume":"2016","author":"Leong","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.freeradbiomed.2012.08.006","article-title":"Schisandrin B Exhibits Anti-Inflammatory Activity through Modulation of the Redox-Sensitive Transcription Factors Nrf2 and NF-\u03baB","volume":"53","author":"Checker","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1248\/bpb.b15-01020","article-title":"Protective Effect of Gomisin N against Endoplasmic Reticulum Stress-Induced Hepatic Steatosis","volume":"39","author":"Jang","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"ref_117","first-page":"1860","article-title":"Inhibition of Fas\/FasL mRNA Expression and TNF-Alpha Release in Concanavalin A-Induced Liver Injury in Mice by Bicyclol","volume":"10","author":"Li","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"ref_118","first-page":"1772","article-title":"Protective Effects of Bicyclol on Liver Fibrosis Induced by Carbon Tetrachloride","volume":"84","author":"Li","year":"2004","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1478-3231.2005.01103.x","article-title":"Mechanism of Protective Action of Bicyclol against CCl4-Induced Liver Injury in Mice","volume":"25","author":"Liu","year":"2005","journal-title":"Liver Int."},{"key":"ref_120","first-page":"33","article-title":"Protective Effect of Bicyclol on Acute Hepatic Failure Induced by Lipopolysaccharide and D-Galactosamine in Mice","volume":"540","author":"Wang","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"189","DOI":"10.31083\/ph.2010.9679","article-title":"Bicyclol Attenuates Pro-Inflammatory Cytokine and Chemokine Productions in CpG-DNA-Stimulated L02 Hepatocytes by Inhibiting p65-NF-\u03baB and p38-MAPK Activation","volume":"65","author":"Lou","year":"2010","journal-title":"Pharmazie"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Zhao, T.M., Wang, Y., Deng, Y., Fan, X.F., Cao, X.C., Hou, L.J., Mao, L.H., Lin, L., Zhao, W., and Wang, B.M. (2020). Bicyclol Attenuates Acute Liver Injury by Activating Autophagy, Anti-Oxidative and Anti-Inflammatory Capabilities in Mice. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00463"},{"key":"ref_123","first-page":"1035","article-title":"Effects of Bicyclol on Aflatoxin B1 Metabolism and Hepatotoxicity in Rats","volume":"23","author":"Lu","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tox.2009.04.058","article-title":"Protective effect of bicyclol on tetracycline-induced fatty liver in mice","volume":"261","author":"Yu","year":"2009","journal-title":"Toxicology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.26719\/2002.8.1.95","article-title":"Effect of Dimethyl Diphenyl Bicarboxylate on Normal and Chemically-Injured Liver","volume":"8","year":"2002","journal-title":"East Mediterr. Health J."},{"key":"ref_126","first-page":"300","article-title":"The Effect of Dimethyl Dimethoxy Biphenyl Dicarboxylate (DDB) against Tamoxifen-Induced Liver Injury in Rats: DDB Use Is Curative or Protective","volume":"38","year":"2005","journal-title":"J. Biochem. Mol. Biol."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Wang, J.H., Hwang, S.J., and Son, C.G. (2021). Comparative Analysis of the Antioxidative and Hepatoprotective Activities of Dimethyl Diphenyl Bicarboxylate in Four Animal Models of Hepatic Injury. Antioxidants, 10.","DOI":"10.3390\/antiox10101508"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/0748233713498445","article-title":"Dimethyl Dimethoxy Biphenyl Dicarboxylate Attenuates Hepatic and Metabolic Alterations in High Fructose-Fed Rats","volume":"32","author":"Morsy","year":"2016","journal-title":"Toxicol. Ind. Health"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11064-015-1513-5","article-title":"Gastrodin Alleviates Cerebral Ischemic Damage in Mice by Improving Antioxidant and Anti-Inflammation Activities and Inhibiting Apoptosis Pathway","volume":"40","author":"Peng","year":"2015","journal-title":"Neurochem. Res."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Dai, J.N., Zong, Y., Zhong, L.M., Li, Y.M., Zhang, W., Bian, L.G., Ai, Q.L., Liu, Y.D., Sun, J., and Lu, D. (2011). Gastrodin Inhibits Expression of Inducible NO Synthase, Cyclooxygenase-2 and Proinflammatory Cytokines in Cultured LPS-Stimulated Microglia via MAPK Pathways. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021891"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuint.2014.06.003","article-title":"Gastrodin Protects against MPP(+)-Induced Oxidative Stress by Upregulating Heme Oxygenase-1 Expression through the p38 MAPK\/Nrf2 Pathway in Human Dopaminergic Cells","volume":"75","author":"Jiang","year":"2014","journal-title":"Neurochem. Int."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Ahmad, O., Wang, B., Ma, K., Deng, Y., Li, M., Yang, L., Yang, Y., Zhao, J., Cheng, L., and Zhou, Q. (2019). Lipid Modulating Antioxidant Stress Activity of Gastrodin on Nonalcoholic Fatty Liver Disease Larval Zebrafish Model. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081984"},{"key":"ref_133","first-page":"39","article-title":"Gastrodin Ameliorates Oleic Acid\u2013Induced Fat Accumulation through Activation of the AMPK Pathway in HL-7702 Cells","volume":"31","author":"Geng","year":"2015","journal-title":"Chin. Pharmacol. Bull."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ptr.5541","article-title":"Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK\/Nrf2 Pathway","volume":"30","author":"Qu","year":"2016","journal-title":"Phytother. Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1774","article-title":"Long-Term Pioglitazone Treatment for Patients with Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Dai, Y., Ban, W., and Yang, Z. (2024). Gastrodin, a Promising Natural Small Molecule for the Treatment of Central Nervous System Disorders, and Its Recent Progress in Synthesis, Pharmacology and Pharmacokinetics. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179540"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1039\/c3fo00013c","article-title":"Antioxidant Effect of Salidroside and Its Protective Effect against Furan-Induced Hepatocyte Damage in Mice","volume":"4","author":"Yuan","year":"2013","journal-title":"Food Funct."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Yang, Z.R., Wang, H.F., Zuo, T.C., Guan, L.L., and Dai, N. (2016). Salidroside Alleviates Oxidative Stress in the Liver with Nonalcoholic Steatohepatitis in Rats. BMC Pharmacol. Toxicol., 17.","DOI":"10.1186\/s40360-016-0059-8"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e850","DOI":"10.1038\/cddis.2013.374","article-title":"HIV gp120- and Methamphetamine-Mediated Oxidative Stress Induces Astrocyte Apoptosis via Cytochrome P450 2E1","volume":"4","author":"Shah","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Fei, S.F., Hou, C., and Jia, F. (2024). Effects of Salidroside on Atherosclerosis: Potential Contribution of Gut Microbiota. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1400981"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"952943","DOI":"10.1155\/2014\/952943","article-title":"A Review on Protocatechuic Acid and Its Pharmacological Potential","volume":"2014","author":"Kakkar","year":"2014","journal-title":"ISRN Pharmacol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1179\/174329210X12650506623285","article-title":"Antioxidant and Antihyperlipidaemic Activity of Protocatechuic Acid on Streptozotocin-Diabetic Rats","volume":"15","author":"Harini","year":"2010","journal-title":"Redox Rep."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/mnfr.201400816","article-title":"Protocatechuic Acid Activates Key Components of the Insulin Signaling Pathway Mimicking Insulin Activity","volume":"59","author":"Scazzocchio","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/jbcpp-2015-0135","article-title":"Effect of Protocatechuic Acid on Lipid Profile and DNA Damage in D-Galactosamine-Induced Hepatotoxic Rats","volume":"27","author":"Radhiga","year":"2016","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3748\/wjg.v17.i16.2086","article-title":"Effects of Alpha-Mangostin on Apoptosis Induction of Human Colon Cancer","volume":"17","author":"Watanapokasin","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3892\/ijmm.2022.5176","article-title":"The Metabolic and Molecular Mechanisms of \u03b1-Mangostin in Cardiometabolic Disorders (Review)","volume":"50","author":"John","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Kim, H.M., Kim, Y.M., Huh, J.H., Lee, E.S., Kwon, M.H., Lee, B.R., Ko, H.J., and Chung, C.H. (2017). \u03b1-Mangostin Ameliorates Hepatic Steatosis and Insulin Resistance by Inhibition of C\u2013C Chemokine Receptor 2. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179204"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s13318-015-0283-4","article-title":"A Method of Effectively Improved \u03b1-Mangostin Bioavailability","volume":"41","author":"Zhao","year":"2016","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/jf4004434","article-title":"\u03b1-Mangostin: Anti-Inflammatory Activity and Metabolism by Human Cells","volume":"61","author":"Chitchumroonchokchai","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1021\/jf990845y","article-title":"Antioxidative and Anti-Glycation Activity of Garcinol from Garcinia indica Fruit Rind","volume":"48","author":"Yamaguchi","year":"2000","journal-title":"J. Agric. Food Chem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1021\/jf001129v","article-title":"Induction of Apoptosis by Garcinol and Curcumin through Cytochrome c Release and Activation of Caspases in Human Leukemia HL-60 Cells","volume":"49","author":"Pan","year":"2001","journal-title":"J. Agric. Food Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1039\/C4FO00342J","article-title":"Protective Effects of Garcinol on Dimethylnitrosamine-Induced Liver Fibrosis in Rats","volume":"5","author":"Hung","year":"2014","journal-title":"Food Funct."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.intimp.2017.01.016","article-title":"Curcumin Ameliorates Liver Damage and Progression of NASH in NASH\u2013HCC Mouse Model Possibly by Modulating HMGB1\u2013NF-\u03baB Translocation","volume":"44","author":"Afrin","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Lee, G.H., Lee, H.Y., Choi, M.K., Chung, H.W., Kim, S.W., and Chae, H.J. (2017). Protective Effect of Curcuma longa L. Extract on CCl4-Induced Acute Hepatic Stress. BMC Res. Notes, 10.","DOI":"10.1186\/s13104-017-2409-z"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/mol.107.039818","article-title":"Curcumin Protects the Rat Liver from CCl4-Caused Injury and Fibrogenesis by Attenuating Oxidative Stress and Suppressing Inflammation","volume":"73","author":"Fu","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1038\/s41598-020-64293-w","article-title":"Novel Combinatorial Regimen of Garcinol and Curcuminoids for Non-Alcoholic Steatohepatitis (NASH) in Mice","volume":"10","author":"Majeed","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"e4144","DOI":"10.1002\/fsn3.4144","article-title":"Therapeutic Effects of Curcumin Supplementation on Liver Enzymes of Nonalcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis of Randomized Clinical Trials","volume":"13","author":"Ebrahimzadeh","year":"2024","journal-title":"Food Sci. Nutr."},{"key":"ref_158","first-page":"1015","article-title":"Curcumin and Saroglitazar Attenuate Diet-Induced Nonalcoholic Steatohepatitis by Activating the Nrf2 Pathway and Suppressing ERK1\/2 Signaling","volume":"27","author":"Afarin","year":"2024","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"112575","DOI":"10.1016\/j.isci.2025.112575","article-title":"A Pharmacokinetic Study and Critical Reappraisal of Curcumin Formulations Enhancing Bioavailability","volume":"28","author":"Kroon","year":"2025","journal-title":"iScience"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"rqad017","DOI":"10.1093\/rpsppr\/rqad017","article-title":"A Unique In Vivo Pharmacokinetic Profile, In Vitro Metabolic Stability, and Hepatic First-Pass Metabolism of Garcinol, a Promising Novel Anticancer Phytoconstituent, by Liquid Chromatography\u2013Mass Spectrometry","volume":"2","author":"Gajula","year":"2023","journal-title":"RPS Pharm. Pharmacol. Rep."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00795-019-00216-7","article-title":"The Therapeutic Effects of Resveratrol on Hepatic Steatosis in High-Fat Diet-Induced Obese Mice by Improving Oxidative Stress, Inflammation, and Lipid-Related Gene Transcriptional Expression","volume":"52","author":"Cheng","year":"2019","journal-title":"Med. Mol. Morphol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","article-title":"SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function","volume":"15","author":"Price","year":"2012","journal-title":"Cell Metab."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.4161\/auto.26336","article-title":"Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway","volume":"9","author":"Chen","year":"2013","journal-title":"Autophagy"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nut.2016.09.001","article-title":"Alternative Treatment Methods: Molecular Mechanisms and Clinical Trials","volume":"34","author":"Charytoniuk","year":"2017","journal-title":"Nutrition"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"7402645","DOI":"10.1155\/2020\/7402645","article-title":"Resveratrol Improves Hepatic Redox Status and Lipid Balance of Neonates with Intrauterine Growth Retardation in a Piglet Model","volume":"2020","author":"Cheng","year":"2020","journal-title":"Biomed Res. Int."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Zakaria, S.S., and Hanafy, S.M. (2025). Unraveling the Beneficial Role of Resveratrol in Fructose-Induced Nonalcoholic Steatohepatitis with a Focus on the AMPK\/Nrf2 Signaling Axis. Medicina, 61.","DOI":"10.3390\/medicina61010139"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Intagliata, S., Modica, M.N., Santagati, L.M., and Montenegro, L. (2019). Strategies to Improve Resveratrol Systemic and Topical Bioavailability: An Update. Antioxidants, 8.","DOI":"10.3390\/antiox8080244"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"MAESTRO-NASH Investigators. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/GME.0000000000000187","article-title":"Resveratrol- and Melatonin-Abated Ovariectomy and Fructose Diet-Induced Obesity and Metabolic Alterations in Female Rats","volume":"21","author":"Majumdar","year":"2014","journal-title":"Menopause"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1210\/en.2003-0693","article-title":"Melatonin Reduces Body Weight Gain in Sprague\u2013Dawley Rats with Diet-Induced Obesity","volume":"144","author":"Desbazeille","year":"2003","journal-title":"Endocrinology"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","article-title":"Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases","volume":"148","author":"Park","year":"2012","journal-title":"Cell"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/mnfr.201500016","article-title":"Resveratrol Improves Hepatic Steatosis by Inducing Autophagy through the cAMP Signaling Pathway","volume":"59","author":"Zhang","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"119494","DOI":"10.1016\/j.lfs.2021.119494","article-title":"A Tumorigenic Cell Line Derived from a Hamster Cholangiocarcinoma Associated with Opisthorchis felineus Liver Fluke Infection","volume":"277","author":"Mordvinov","year":"2021","journal-title":"Life Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.18632\/aging.101054","article-title":"An Antioxidant Specifically Targeting Mitochondria Delays Progression of Alzheimer\u2019s Disease-Like Pathology","volume":"8","author":"Stefanova","year":"2016","journal-title":"Aging"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.actatropica.2021.105954","article-title":"Antioxidants Resveratrol and SkQ1 Attenuate Praziquantel Adverse Effects on the Liver in Opisthorchis felineus-Infected Hamsters","volume":"220","author":"Zaparina","year":"2021","journal-title":"Acta Trop."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1039\/c3fo60630a","article-title":"Effects of Resveratrol on Gut Microbiota and Fat Storage in a Mouse Model with High-Fat-Induced Obesity","volume":"5","author":"Qiao","year":"2014","journal-title":"Food Funct."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"108363","DOI":"10.1016\/j.jnutbio.2020.108363","article-title":"Targeting the Gut Microbiota with Resveratrol: A Demonstration of Novel Evidence for the Management of Hepatic Steatosis","volume":"81","author":"Wang","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/jgh.13151","article-title":"Effect of Resveratrol on Experimental Non-Alcoholic Fatty Liver Disease Depends on Severity of Pathology and Timing of Treatment","volume":"31","author":"Hellberg","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Bujanda, L., Hijona, E., Larzabal, M., Beraza, M., Aldazabal, P., Garc\u00eda-Urkia, N., Sarasqueta, C., Cosme, A., Irastorza, B., and Gonz\u00e1lez, A. (2008). Resveratrol Inhibits Nonalcoholic Fatty Liver Disease in Rats. BMC Gastroenterol., 8.","DOI":"10.1186\/1471-230X-8-40"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jhep.2008.08.012","article-title":"Dietary Resveratrol Alters Lipid Metabolism-Related Gene Expression of Mice on an Atherogenic Diet","volume":"49","author":"Ahn","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"525094","DOI":"10.1155\/2011\/525094","article-title":"Distinct Effects of Calorie Restriction and Resveratrol on Diet-Induced Obesity and Fatty Liver Formation","volume":"2011","author":"Tauriainen","year":"2011","journal-title":"J. Nutr. Metab."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3109\/00365521.2015.1107620","article-title":"Placebo-Controlled, Randomised Clinical Trial: High-Dose Resveratrol Treatment for Non-Alcoholic Fatty Liver Disease","volume":"51","author":"Kreuzfeldt","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","article-title":"Resveratrol Supplementation Improves Inflammatory Biomarkers in Patients with Nonalcoholic Fatty Liver Disease","volume":"34","author":"Faghihzadeh","year":"2014","journal-title":"Nutr. Res."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.cgh.2014.02.024","article-title":"Resveratrol Does Not Benefit Patients with Nonalcoholic Fatty Liver Disease","volume":"12","author":"Chachay","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jep.2014.03.042","article-title":"In Vitro Effects of Active Components of Polygonum multiflorum Radix on Enzymes Involved in Lipid Metabolism","volume":"153","author":"Wang","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"3641960","DOI":"10.1155\/2018\/3641960","article-title":"Biological Effects of Tetrahydroxystilbene Glucoside: An Active Component Extracted from Polygonum multiflorum Rhizome","volume":"2018","author":"Zhang","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"110138","DOI":"10.1016\/j.biopha.2020.110138","article-title":"2,3,5,4\u2032-Tetrahydroxystilbene-2-O-\u03b2-d-Glucoside Attenuates Hepatic Steatosis via IKK\u03b2\/NF-\u03baB and Keap1-Nrf2 Pathways in Larval Zebrafish","volume":"127","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Wang, C., Dai, S., Gong, L., Fu, K., Ma, C., Liu, Y., Zhou, H., and Li, Y. (2022). A Review of Pharmacology, Toxicity, and Pharmacokinetics of 2,3,5,4\u2032-Tetrahydroxystilbene-2-O-\u03b2-d-Glucoside. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.791214"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3748\/wjg.v23.i7.1125","article-title":"Therapeutic Mechanism of Yin-Chen-Hao Decoction in Hepatic Diseases","volume":"23","author":"Li","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"105170","DOI":"10.1016\/j.phrs.2020.105170","article-title":"Scoparone as a Therapeutic Drug in Liver Diseases: Pharmacology, Pharmacokinetics and Molecular Mechanisms of Action","volume":"160","author":"Hui","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.foodchem.2013.04.036","article-title":"Scoparone Inhibits Adipocyte Differentiation through Down-Regulation of Peroxisome Proliferator-Activated Receptor Gamma in 3T3-L1 Preadipocytes","volume":"141","author":"Noh","year":"2013","journal-title":"Food Chem."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11010-016-2772-4","article-title":"Dimethylesculetin Ameliorates Maternal Glucose Intolerance and Fetal Overgrowth in High-Fat Diet-Fed Pregnant Mice via Constitutive Androstane Receptor","volume":"419","author":"Masuyama","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0960327116649675","article-title":"Influence of Coumarin and Some Coumarin Derivatives on Serum Lipid Profiles in Carbon Tetrachloride-Exposed Rats","volume":"36","author":"Tasdemir","year":"2017","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"105797","DOI":"10.1016\/j.intimp.2019.105797","article-title":"Scoparone Alleviates Inflammation, Apoptosis and Fibrosis of Non-Alcoholic Steatohepatitis by Suppressing the TLR4\/NF-\u03baB Signaling Pathway in Mice","volume":"75","author":"Liu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"109895","DOI":"10.1016\/j.biopha.2020.109895","article-title":"Scoparone Improves Hepatic Inflammation and Autophagy in Mice with Nonalcoholic Steatohepatitis by Regulating the ROS\/P38\/Nrf2 Axis and PI3K\/AKT\/mTOR Pathway in Macrophages","volume":"125","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10753-019-00973-8","article-title":"Umbelliferone Ameliorates CCl4-Induced Liver Fibrosis in Rats by Upregulating PPAR\u03b3 and Attenuating Oxidative Stress, Inflammation, and TGF-\u03b21\/Smad3 Signaling","volume":"42","author":"Mahmoud","year":"2019","journal-title":"Inflammation"},{"key":"ref_197","first-page":"346","article-title":"Umbelliferone Ameliorates Renal Function in Diabetic Nephropathy Rats through Regulating Inflammation and the TLR\/NF-\u03baB Pathway","volume":"17","author":"Wang","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3349\/ymj.2022.0354","article-title":"Umbelliferone Ameliorates Hepatic Steatosis and Lipid-Induced ER Stress in High-Fat Diet-Induced Obese Mice","volume":"64","author":"Park","year":"2023","journal-title":"Yonsei Med. J."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.2147\/IJN.S136629","article-title":"Fabrication, Optimization, and Characterization of Umbelliferone \u03b2-D-Galactopyranoside-Loaded PLGA Nanoparticles in Treatment of Hepatocellular Carcinoma: In Vitro and In Vivo Studies","volume":"12","author":"Kumar","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"K\u00fcpeli Akkol, E., Gen\u00e7, Y., Karpuz, B., Sobarzo-S\u00e1nchez, E., and Capasso, R. (2020). Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer. Cancers, 12.","DOI":"10.3390\/cancers12071959"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2013.06.012","article-title":"Wedelolactone Exhibits Anti-Fibrotic Effects on Human Hepatic Stellate Cell Line LX-2","volume":"714","author":"Xia","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jep.2014.09.033","article-title":"Inhibitory Effect of Ecliptae herba Extract and Its Component Wedelolactone on Pre-Osteoclastic Proliferation and Differentiation","volume":"157","author":"Liu","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Peng, L., Yang, L.C., Xu, X.D., Li, W.J., Luo, X.M., and Jin, X. (2015). Wedelolactone Regulates Lipid Metabolism and Improves Hepatic Steatosis Partly by AMPK Activation and Up-Regulation of PPAR\u03b1\/LPL and LDLR Expression. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132720"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Su, M., Huang, W., and Zhu, B. (2016). Acetylshikonin from Zicao Prevents Obesity in Rats on a High-Fat Diet by Inhibiting Lipid Accumulation and Inducing Lipolysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146884"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Su, M.-L., He, Y., Li, Q.-S., and Zhu, B.-H. (2016). Efficacy of Acetylshikonin in Preventing Obesity and Hepatic Steatosis in db\/db Mice. Molecules, 21.","DOI":"10.3390\/molecules21080976"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.bbrc.2018.07.094","article-title":"Autophagy Is Involved in Acetylshikonin Ameliorating Non-Alcoholic Steatohepatitis through the AMPK\/mTOR Pathway","volume":"503","author":"Zeng","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.intimp.2011.07.018","article-title":"Cryptotanshinone Inhibits LPS-Induced Proinflammatory Mediators via the TLR4 and TAK1 Signaling Pathways","volume":"11","author":"Li","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10753-010-9214-3","article-title":"Cryptotanshinone Suppresses Inflammatory Cytokine Secretion in RAW264.7 Macrophages through Inhibition of NF-\u03baB and MAPK Signaling Pathways","volume":"34","author":"Tang","year":"2011","journal-title":"Inflammation"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Nagappan, A., Kim, J.H., Jung, D.Y., and Jung, M.H. (2019). Cryptotanshinone from Salvia miltiorrhiza Bunge Attenuates Ethanol-Induced Liver Injury by Activation of AMPK\/SIRT1 and Nrf2 Signaling Pathways. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010265"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"108676","DOI":"10.1016\/j.biopha.2019.108676","article-title":"Preventive and Therapeutic Role of Tanshinone IIA in Hepatology","volume":"112","author":"Shi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_211","first-page":"31","article-title":"Effect of Tanshinone IIA on CCl4-Induced Liver Fibrosis in Rats","volume":"25","author":"Liu","year":"2002","journal-title":"Zhong Yao Cai"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.3390\/molecules19068189","article-title":"Standardized Salvia miltiorrhiza Extract Suppresses Hepatic Stellate Cell Activation and Attenuates Steatohepatitis Induced by a Methionine-Choline Deficient Diet in Mice","volume":"19","author":"Lee","year":"2014","journal-title":"Molecules"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bcp.2011.09.029","article-title":"Thymoquinone: Potential Cure for Inflammatory Disorders and Cancer","volume":"83","author":"Woo","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"42995","DOI":"10.1038\/srep42995","article-title":"Thymoquinone: An IRAK1 Inhibitor with In Vivo and In Vitro Anti-Inflammatory Activities","volume":"7","author":"Hossen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00210-015-1207-1","article-title":"Thymoquinone Alleviates Nonalcoholic Fatty Liver Disease in Rats via Suppression of Oxidative Stress, Inflammation, and Apoptosis","volume":"389","author":"Awad","year":"2016","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_216","first-page":"479","article-title":"Thymoquinone reverses nonalcoholic fatty liver disease (NAFLD) associated with experimental hypothyroidism","volume":"60","author":"Ayuob","year":"2019","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ptr.5631","article-title":"Emodin: A Review of Its Pharmacology, Toxicity, and Pharmacokinetics","volume":"30","author":"Dong","year":"2016","journal-title":"Phytother. Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1039\/C4TX00246F","article-title":"Metabolomic Profiling of Emodin-Induced Cytotoxicity in Human Liver Cells and Mechanistic Study","volume":"4","author":"Liu","year":"2015","journal-title":"Toxicol. Res."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.fsi.2014.02.018","article-title":"The Effect of Emodin on Cytotoxicity, Apoptosis, and Antioxidant Capacity in the Hepatic Cells of Grass Carp (Ctenopharyngodon idellus)","volume":"38","author":"Cui","year":"2014","journal-title":"Fish Shellfish Immunol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3748\/wjg.v11.i9.1339","article-title":"Effects of Emodin on Treating Murine Nonalcoholic Fatty Liver Induced by High-Caloric Laboratory Chow","volume":"11","author":"Dong","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.3390\/ijms13022276","article-title":"Emodin Prevents Intrahepatic Fat Accumulation, Inflammation, and Redox Status Imbalance during Diet-Induced Hepatosteatosis in Rats","volume":"13","author":"Alisi","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Chang, C.H., Hsu, C.C., Lee, A.S., Wang, S.W., Lin, K.T., Chang, W.L., Peng, H.C., Huang, W.C., and Chung, C.H. (2018). 4-Acetylantroquinonol B Inhibits Lipopolysaccharide-Induced Cytokine Release and Alleviates Sepsis through MAPK and NF-\u03baB Suppression. BMC Complement. Altern. Med., 18.","DOI":"10.1186\/s12906-018-2172-2"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.biopha.2018.11.101","article-title":"4-Acetylantroquinonol B from Antrodia cinnamomea Enhances Immune Function of Dendritic Cells against Liver Cancer Stem Cells","volume":"109","author":"Li","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"111504","DOI":"10.1016\/j.biopha.2021.111504","article-title":"4-Acetylantroquinonol B Ameliorates Nonalcoholic Steatohepatitis by Suppression of ER Stress and NLRP3 Inflammasome Activation","volume":"138","author":"Yen","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Farooqi, A.A., Wen, R., Attar, R., Taverna, S., Butt, G., and Xu, B. (2022). Regulation of Cell-Signaling Pathways by Berbamine in Different Cancers. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052758"},{"key":"ref_226","first-page":"801","article-title":"Berbamine Ameliorates Ethanol-Induced Liver Injury by Inhibition of Hepatic Inflammation in Mice","volume":"18","author":"Liu","year":"2020","journal-title":"Chin. J. Nat. Med."},{"key":"ref_227","first-page":"173128","article-title":"Berbamine-Induced AMPK Activation Regulates the mTOR\/SREBP-1c Axis and Nrf2\/ARE Pathway to Allay Lipid Accumulation and Oxidative Stress in Steatotic HepG2 Cells","volume":"879","author":"Sharma","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/jpet.114.219832","article-title":"Demethyleneberberine, a Natural Mitochondria-Targeted Antioxidant, Inhibits Mitochondrial Dysfunction, Oxidative Stress, and Steatosis in an Alcoholic Liver Disease Mouse Model","volume":"352","author":"Zhang","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bbrc.2016.03.019","article-title":"Demethyleneberberine Attenuates Non-Alcoholic Fatty Liver Disease with Activation of AMPK and Inhibition of Oxidative Stress","volume":"472","author":"Qiang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1016\/j.bmc.2015.05.057","article-title":"Discovery of Natural Alkaloid Bouchardatine as a Novel Inhibitor of Adipogenesis\/Lipogenesis in 3T3-L1 Adipocytes","volume":"23","author":"Rao","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"35625","DOI":"10.1074\/jbc.M203913200","article-title":"Insulin and Sterol-Regulatory Element-Binding Protein-1c (SREBP-1C) Regulation of Gene Expression in 3T3-L1 Adipocytes: Identification of CCAAT\/Enhancer-Binding Protein \u03b2 as an SREBP-1C Target","volume":"277","author":"Trautwein","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0006-291X(02)02860-7","article-title":"Regulation of PPAR\u03b3 Transcriptional Activity in 3T3-L1 Adipocytes","volume":"300","author":"Watanabe","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/bph.14713","article-title":"Bouchardatine Analogue Alleviates Non-Alcoholic Hepatic Fatty Liver Disease\/Non-Alcoholic Steatohepatitis in High-Fat-Fed Mice by Inhibiting ATP Synthase Activity","volume":"176","author":"Rao","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jff.2012.09.003","article-title":"Ankaflavin regulates adipocyte function and attenuates hyperglycemia caused by high-fat diet via PPAR-gamma activation","volume":"5","author":"Hsu","year":"2013","journal-title":"J. Funct. Foods"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1007\/s00253-014-5716-5","article-title":"Treatment of metabolic syndrome with ankaflavin, a secondary metabolite isolated from the edible fungus Monascus spp","volume":"98","author":"Hsu","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.fct.2013.11.015","article-title":"Monascin and ankaflavin act as natural AMPK activators with PPAR\u03b1 agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL\/6 mice","volume":"64","author":"Hsu","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"952031","DOI":"10.1093\/ecam\/nep241","article-title":"Anti-obesity and anti-diabetic effects of Acacia polyphenol in obese diabetic KKAy mice fed high-fat diet","volume":"2011","author":"Ikarashi","year":"2011","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1499-3872(15)60361-7","article-title":"Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in mice","volume":"14","author":"Yang","year":"2015","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Erlich, M.N., Ghidanac, D., Blanco Mejia, S., Ayoub-Charette, S., Vittes Combe, C., Khan, T.A., Ramdath, D., Crewson, H., Beck, A., and Silva, C. (2026). Rationale, Design, and Participant Baseline Characteristics of a Parallel Randomized Trial of the Effect of Replacing SSBs with Cow\u2019s Milk Versus Soymilk on Intrahepatocellular Lipid and Other Cardiometabolic Risk Factors in Adults with Obesity Who Consume Sugar-Sweetened Beverages: The Soy Treatment Evaluation for Metabolic Health (STEM) Trial. Nutrients, 18.","DOI":"10.3390\/nu18071026"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"100125","DOI":"10.1016\/j.pharmr.2026.100125","article-title":"Emerging Natural Products against Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease\/Metabolic Dysfunction-Associated Steatohepatitis: Direct Target Discovery and Mechanistic Insights","volume":"78","author":"Hu","year":"2026","journal-title":"Pharmacol. Rev."},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Madhankumar, S., and Asma, A. (2026). Advances in the Pharmacologic Management of MASLD. Gastroenterol. Insights, 17.","DOI":"10.3390\/gastroent17010017"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.2147\/IJN.S510271","article-title":"Therapeutic Nanomaterials in NAFLD: Current Advances and Potential Applications in Patients with Concurrent HBV Infection","volume":"20","author":"Li","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41575-023-00797-w","article-title":"Nanoparticles in NAFLD Therapeutics","volume":"20","author":"Kotsiliti","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s44301-025-00010-8","article-title":"Natural Lipid-Based Nanoformulations for Enhancing Hepatoprotective Activity: Mechanisms, Efficacy, and Clinical Translation","volume":"1","author":"Patel","year":"2025","journal-title":"Health Nanotechnol."},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Parvin, N., Aslam, M., Joo, S.W., and Mandal, T.K. (2025). Nano-Phytomedicine: Harnessing Plant-Derived Phytochemicals in Nanocarriers for Targeted Human Health Applications. Molecules, 30.","DOI":"10.3390\/molecules30153177"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s40001-026-03901-3","article-title":"Multi-Strain Synbiotic and Lifestyle Modifications on Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Randomized Double-Blinded Placebo-Controlled Trial","volume":"31","author":"Abbasian","year":"2026","journal-title":"Eur. J. Med. Res."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.joim.2024.04.005","article-title":"Advancements in Nanotechnology for the Delivery of Phytochemicals","volume":"22","author":"Chauhan","year":"2024","journal-title":"J. Integr. Med."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/cpt.3606","article-title":"Insights into Clinical Trials for Drugs Targeting MASLD: Progress, Challenges, and Future Directions","volume":"117","author":"Wu","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1097\/CM9.0000000000003355","article-title":"Drug Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress and Direction","volume":"137","author":"Zhou","year":"2024","journal-title":"Chin. Med. J."},{"key":"ref_250","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2024). EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). J. Hepatol., 81, 492\u2013542."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/5\/465\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:15:59Z","timestamp":1778645759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/5\/465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":250,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["cimb48050465"],"URL":"https:\/\/doi.org\/10.3390\/cimb48050465","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}